Literature DB >> 18706279

Triglycerides and risk for coronary artery disease.

Patrick McBride1.   

Abstract

Triglycerides (TGs) are now considered an independent risk factor for cardiovascular disease (CVD). When TGs are elevated, lipoprotein metabolism is altered, which increases CVD risk. Patients with elevated TGs and low high-density lipoprotein are at particularly high risk of CVD. TGs are often associated with other CVD risk factors, such as obesity, insulin resistance, diabetes mellitus, low HDL cholesterol, lifestyle factors, and changes in lipoprotein size and density. Elevated TGs remain an independent risk even when controlling for the other factors and are a greater risk for women than men. Treatment of elevated TGs in clinical trials has been shown to reduce CVD events, cardiac deaths, and total mortality.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18706279     DOI: 10.1007/s11883-008-0060-9

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  45 in total

Review 1.  Lipid management to reduce cardiovascular risk: a new strategy is required.

Authors:  H Robert Superko; Spencer King
Journal:  Circulation       Date:  2008-01-29       Impact factor: 29.690

2.  Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

Authors:  M A Austin; M C King; K M Vranizan; R M Krauss
Journal:  Circulation       Date:  1990-08       Impact factor: 29.690

3.  Atorvastatin reduces postprandial accumulation and cholesteryl ester transfer protein-mediated remodeling of triglyceride-rich lipoprotein subspecies in type IIb hyperlipidemia.

Authors:  Maryse Guerin; Pascal Egger; Wilfried Le Goff; Céline Soudant; Reynald Dupuis; M John Chapman
Journal:  J Clin Endocrinol Metab       Date:  2002-11       Impact factor: 5.958

4.  Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease.

Authors:  Paul N Hopkins; Lily L Wu; Steven C Hunt; Eliot A Brinton
Journal:  J Am Coll Cardiol       Date:  2005-04-05       Impact factor: 24.094

5.  Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  A R Sharrett; C M Ballantyne; S A Coady; G Heiss; P D Sorlie; D Catellier; W Patsch
Journal:  Circulation       Date:  2001-09-04       Impact factor: 29.690

6.  Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.

Authors:  Paul M Ridker; Nader Rifai; Nancy R Cook; Gary Bradwin; Julie E Buring
Journal:  JAMA       Date:  2005-07-20       Impact factor: 56.272

7.  Increasing prevalence of the metabolic syndrome among u.s. Adults.

Authors:  Earl S Ford; Wayne H Giles; Ali H Mokdad
Journal:  Diabetes Care       Date:  2004-10       Impact factor: 19.112

8.  Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.

Authors:  J E Hokanson; M A Austin
Journal:  J Cardiovasc Risk       Date:  1996-04

9.  Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia.

Authors:  R G Bakker-Arkema; M H Davidson; R J Goldstein; J Davignon; J L Isaacsohn; S R Weiss; L M Keilson; W V Brown; V T Miller; L J Shurzinske; D M Black
Journal:  JAMA       Date:  1996-01-10       Impact factor: 56.272

10.  Alcohol consumption and lipoprotein subclasses in older adults.

Authors:  Kenneth J Mukamal; Rachel H Mackey; Lewis H Kuller; Russell P Tracy; Richard A Kronmal; Murray A Mittleman; David S Siscovick
Journal:  J Clin Endocrinol Metab       Date:  2007-04-17       Impact factor: 5.958

View more
  23 in total

1.  Prothrombotic markers in asymptomatic dyslipidemic subjects.

Authors:  David Karasek; Helena Vaverkova; Milan Halenka; Dagmar Jackuliakova; Zdenek Frysak; Ludek Slavik; Dalibor Novotny
Journal:  J Thromb Thrombolysis       Date:  2011-01       Impact factor: 2.300

2.  Understanding the connection between spiritual well-being and physical health: an examination of ambulatory blood pressure, inflammation, blood lipids and fasting glucose.

Authors:  Julianne Holt-Lunstad; Patrick R Steffen; Jonathan Sandberg; Bryan Jensen
Journal:  J Behav Med       Date:  2011-04-13

3.  Genome-wide association study identifies novel recessive genetic variants for high TGs in an Arab population.

Authors:  Prashantha Hebbar; Rasheeba Nizam; Motasem Melhem; Fadi Alkayal; Naser Elkum; Sumi Elsa John; Jaakko Tuomilehto; Osama Alsmadi; Thangavel Alphonse Thanaraj
Journal:  J Lipid Res       Date:  2018-08-14       Impact factor: 5.922

4.  Deficient serum 25-hydroxyvitamin D is associated with an atherogenic lipid profile: The Very Large Database of Lipids (VLDL-3) study.

Authors:  Joshua R Lupton; Kamil F Faridi; Seth S Martin; Sristi Sharma; Krishnaji Kulkarni; Steven R Jones; Erin D Michos
Journal:  J Clin Lipidol       Date:  2015-09-25       Impact factor: 4.766

5.  Cost-effectiveness of extended-release niacin/laropiprant added to a stable simvastatin dose in secondary prevention patients not at cholesterol goal in Germany.

Authors:  Galin V Michailov; Glenn M Davies; Karl J Krobot
Journal:  Eur J Health Econ       Date:  2011-04-05

6.  Prevalence of dyslipidaemia in statin-treated patients in Ireland: Irish results of the DYSlipidaemia International Study (DYSIS).

Authors:  S Horgan; J Crowley; J Feely; B McAdam; E Shanahan; C Vaughan
Journal:  Ir J Med Sci       Date:  2011-03-13       Impact factor: 1.568

7.  Global metabolic consequences of the chromogranin A-null model of hypertension: transcriptomic detection, pathway identification, and experimental verification.

Authors:  Ryan S Friese; Jiaur R Gayen; Nitish R Mahapatra; Geert W Schmid-Schönbein; Daniel T O'Connor; Sushil K Mahata
Journal:  Physiol Genomics       Date:  2009-12-01       Impact factor: 3.107

8.  Oxidized high-density lipoprotein is associated with increased plasma glucose in non-diabetic dyslipidemic subjects.

Authors:  Kazuhiko Kotani; Naoki Sakane; Masashi Ueda; Shinichi Mashiba; Yasuyuki Hayase; Kokoro Tsuzaki; Toshiyuki Yamada; Alan T Remaley
Journal:  Clin Chim Acta       Date:  2012-09-06       Impact factor: 3.786

9.  Cardiovascular risk factors in Assyrians/Syrians and native Swedes with type 2 diabetes: a population-based epidemiological study.

Authors:  Marina Taloyan; Alexandre Wajngot; Sven-Erik Johansson; Jonas Tovi; Jan Sundquist
Journal:  Cardiovasc Diabetol       Date:  2009-11-12       Impact factor: 9.951

10.  Beneficial Effects of Hydroalcoholic Extract from Rosa Roxburghii Tratt Fruit on Hyperlipidemia in High-Fat-Fed Rats.

Authors:  Pin-Hsin Wu; Samuel Chieng-Haw Han; Meng-Hsiu Wu
Journal:  Acta Cardiol Sin       Date:  2020-03       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.